Myestra 2mg, Estradiol Valerate, Women’s Health, Hormone Replacement Therapy, Online Pharmacy
Home About us Blog
AntiCancer Drugs DISEASES/SYMPTOMS Menstrual Control Female Hormones HORMONES FEMTECH +4

Myestra 2mg Tablet

★★★★★
★★★★★
0

(0)

Generic For PROGYNOVA
Active Ingredient ESTRADIOL VALERATE
Strength 2MG
Manufacturer MYLAN
Myestra 2 14 tablets box and blister pack estradiol estrogen hormone therapy online pharmacy
Myestra 2 14 tablets box and blister pack estradiol estrogen hormone therapy online pharmacy
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 14 TABLETS $ 0.75 $ 10.50
$ 8.93
Apply ZARVY26 (-15%)
You save $ 1.58
2 BOXES - 28 TABLETS $ 0.70
7% $ 21.00
$ 19.60
$ 16.66
Apply ZARVY26 (-15%)
You save $ 2.94
★ Best Value 4 BOXES - 56 TABLETS $ 0.66
12% $ 42.00
$ 36.90
$ 31.37
Apply ZARVY26 (-15%)
You save $ 5.54
See your savings before you checkout!
With code ZARVY26, get the lowest price on every option above.
Coupon
ZARVY26
Discount
15% OFF
Max Savings
$ 5.54 on 4 Boxes
Go to Cart →
🔒 Secure Checkout

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Myestra 2mg Tablet is an oral estrogen therapy containing Estradiol Valerate, a long-acting estrogen ester that is rapidly converted into active estradiol in the body. This formulation is designed for efficient systemic absorption and prolonged hormonal support, making it ideal for treating estrogen deficiency states, menopausal symptoms, and selected oncologic conditions. It serves both therapeutic and preventive roles in managing hormone-related disorders across multiple clinical scenarios.

Indications & Uses

  • HORMONES & MENOPAUSAL SYMPTOMS > Menopausal Hormone Therapy Alleviates vasomotor symptoms such as hot flashes, night sweats, and mood swings caused by estrogen deficiency in postmenopausal women.
  • FEMTECH > Menstrual Control Regulates menstrual cycles in women with amenorrhea, premature menopause, or undergoing hormone modulation.
  • FEMTECH > Vaginal & Urethral Atrophy Restores mucosal health and relieves discomfort associated with genitourinary syndrome of menopause (GSM).
  • LIFESTYLE-RELATED DISEASES > Osteoporosis Prevents bone demineralization and lowers fracture risk in postmenopausal women by maintaining estrogen levels.
  • DISEASES/SYMPTOMS > Hypoestrogenism Effective in managing conditions like ovarian insufficiency and surgical menopause with consistent hormone replacement.
  • AntiCancer Drugs > Prostate Cancer Utilized in male patients for palliative androgen suppression as part of hormone-responsive cancer protocols.
  • AntiCancer Drugs > Breast Cancer Serves as a secondary hormonal intervention in select postmenopausal patients with advanced breast cancer.
  • AntiCancer Drugs > Others (for off-label hormonal modulation) Considered for specialized applications including transgender hormone therapy or refractory endocrine syndromes.

Benefits & Effectiveness

Estradiol Valerate provides a stable and potent source of systemic estrogen. After oral or intramuscular administration, it is enzymatically converted to estradiol, the principal female sex hormone. Estradiol binds to estrogen receptors throughout the body, modulating gene transcription and promoting tissue integrity in bones, brain, cardiovascular structures, and reproductive organs. In oncology, it contributes to hormonal suppression or modulation to influence tumor growth.

Directions for Use

  • Postmenopausal Symptoms - Oral: 1–2 mg per day, preferably in cyclic regimen (21 days on, 7 days off), Transdermal: Vivelle-Dot (biweekly) start at 0.0375–0.05 mg/day, titrate to 0.025–0.1 mg/day, Climara (weekly) begin at 0.025 mg/day; adjust up to 0.1 mg/day if needed, Topicals: Divigel 0.25–1.25 mg/day to thigh, Estrogel/Elestrin 0.52–0.75 mg/day to upper arm, Evamist 1.53 mg once daily (up to 3 sprays) to forearm, Vaginal Ring: Femring every 90 days (0.05–0.1 mg/day), IM Injection: Valerate 10–20 mg every 4 weeks, Cypionate 1–5 mg every 3–4 weeks
  • Atrophic Urethritis / Vaginitis - Oral or topical routes acceptable, depending on symptom localization, Prefer vaginal/topical for GSM with minimal systemic symptoms
  • Hypoestrogenism / Surgical Menopause - Oral: 1–2 mg/day, IM: Estradiol valerate 10–20 mg every 4 weeks or patches for continuous hormone coverage
  • Primary Ovarian Failure - Same dosing as hypoestrogenism, Long-term use typically indicated under supervision
  • Osteoporosis Prevention - Oral: Minimum of 0.5 mg/day recommended, Transdermal: Biweekly patch 0.025 mg/day, Weekly patch 0.025 mg/day (Climara), 0.014 mg/day (Menostar)
  • Breast Cancer (Palliation) - Oral: 10 mg three times daily for ≥3 months in carefully selected postmenopausal patients
  • Prostate Cancer (Hormonal Therapy) - Oral: 1–2 mg three times daily, IM: 30 mg or more estradiol valerate every 1–2 weeks
  • General Notes - Use minimum effective dose for shortest appropriate duration, In women with an intact uterus, combine with progestogen to prevent endometrial hyperplasia, Therapy should be reevaluated regularly (every 3 to 6 months), Monitor for thromboembolic risk, liver function abnormalities, and endometrial changes during long-term therapy

Storage

  • Keep at room temperature, ideally below 25°C, away from direct sunlight and moisture.
  • Store in original blister packaging until use. Do not refrigerate or freeze. Keep out of reach of children.

Possible Side Effects

  • Potential side effects include nausea, breast tenderness, bloating, fluid retention, headache, and mood changes
  • Serious risks include deep vein thrombosis, stroke, myocardial infarction, and gallbladder disease
  • Long-term use requires careful risk assessment
  • Report signs of visual changes, severe headache, or jaundice immediately

FAQs

Symptomatic relief typically begins within 2–4 weeks of continuous therapy.
Yes, with regular medical supervision and risk-benefit assessment every 6 months.
Yes, it is part of hormonal treatment protocols to reduce testosterone levels.
It can regulate or replace cycles in estrogen-deficient women or those with ovarian failure.
Yes, under medical supervision, it is one of the estrogen options used in gender-affirming treatment plans.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.